Locations:
SearchAdvertisement
A co-author explains some of the key McDonald criteria revisions
Investigational gene approaches offer hope for a therapeutically challenging condition
This common condition remains tough to work up and diagnose, and treatment options are limited
It’s time to get familiar with this emerging demyelinating disorder
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
An overview of associated antibodies, therapies for antibody-positive disease and the outlook for atypical forms of MG
A close look at the growing array of options for episodic and chronic migraine
Heightened awareness of this rare disorder may lead to better diagnosis and treatment progress
Insights on the decision process for selecting a treatment approach
New oncologic rehab program is tailored to managing the effects of cancer and its treatments
Determining the right dose and injecting in the right muscle can be challenging
Advertisement
Advertisement